Upgrade to SI Premium - Free Trial

Ingredion (INGR) PT Lowered to $114 at UBS

May 7, 2026 9:48 AM
UBS analyst Joshua Spector lowered the price target on Ingredion (NYSE: INGR) to $114.00 (from $122.00) while maintaining a Neutral rating.

Categories

Analyst PT Change